What Is the Utility of KDIGO Criteria to Identify High-Risk Populations?
Am J Kidney Dis
.
2021 Jan;77(1):7-8.
doi: 10.1053/j.ajkd.2020.10.002.
Authors
Christoph Wanner
1
,
Kai Lopau
2
Affiliations
1
Division of Nephrology, Department of Medicine, University Hospital Würzburg, Würzburg, Germany. Electronic address:
[email protected]
.
2
Division of Nephrology, Department of Medicine, University Hospital Würzburg, Würzburg, Germany.
PMID:
33342463
DOI:
10.1053/j.ajkd.2020.10.002
No abstract available
Publication types
Editorial
Comment
MeSH terms
Canagliflozin*
Humans
Kidney
Numbers Needed To Treat*
Risk Factors
Substances
Canagliflozin